1-4-(3-methyltriazeno)benzoic acid has been researched along with methoxy-morpholinyl-doxorubicin in 1 studies
| Studies (1-4-(3-methyltriazeno)benzoic acid) | Trials (1-4-(3-methyltriazeno)benzoic acid) | Recent Studies (post-2010) (1-4-(3-methyltriazeno)benzoic acid) | Studies (methoxy-morpholinyl-doxorubicin) | Trials (methoxy-morpholinyl-doxorubicin) | Recent Studies (post-2010) (methoxy-morpholinyl-doxorubicin) |
|---|---|---|---|---|---|
| 14 | 1 | 1 | 50 | 6 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvino, E; Bonmassar, E; Cantagallo, D; D'Atri, S; Gatteschi, A; Gilberti, S; Massoud, R; Tentori, L | 1 |
1 other study(ies) available for 1-4-(3-methyltriazeno)benzoic acid and methoxy-morpholinyl-doxorubicin
| Article | Year |
|---|---|
In vitro antitumor activity of 3'-desamino-3'(2-methoxy-4-morpholinyl) doxorubicin on human melanoma cells sensitive or resistant to triazene compounds.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Neoplasm; Glutathione; Glutathione Peroxidase; Melanoma; Triazenes; Tumor Cells, Cultured | 1997 |